2+ day, 17+ hour ago   (207+ words) That’s why the Novel CNS Biomarkers Summit Europe comes at a timely moment, bringing together Europe's leading biomarker, translational medicine, neuroscience and clinical development experts to tackle one of the industry's biggest challenges: improving clinical trial success in CNS drug…...

3+ day, 20+ hour ago   (565+ words) An AI-powered imaging tool developed by Brainomix has been used to enrich data from a phase 2a trial of Endeavor BioMedicines' hedgehog pathway inhibitor taladegib, in development for idiopathic pulmonary fibrosis (IPF). The post hoc analysis of the study showed that…...

1+ week, 5+ day ago   (515+ words) Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to ending overdoses. The fact that 25 years later we still need a dedicated observance speaks to how much work remains…...

3+ week, 1+ day ago   (386+ words) Paris, France-based Bioptimus, a global AI biotech company, has announced a partnership with Cancer Research Horizons, the innovation engine of Cancer Research UK, to advance AI-powered precision medicine. The agreement allows Bioptimus to access S:CORT (Stratification in COloRectal cancer Trial),…...

3+ week, 4+ day ago   (325+ words) Lund, Sweden-based Hansa Biopharma AB has announced that the first commercial patient in Australia has received a living donor kidney transplant following treatment with Idefirix (imlifidase), consistent with the indication approved by the Therapeutic Goods Administration (TGA). Idefirix is approved…...

1+ mon, 20+ hour ago   (506+ words) A kidney transplant patient with a rare, multidrug-resistant (MDR) infection has become the first to be treated using an adjunctive bacteriophage therapy developed by Denmark's SNIPR Biome. The SNIPR001 therapy takes the form of a bacteriophage – a virus that only infects…...

1+ mon, 5+ day ago   (459+ words) National Cancer Institute via Wikimedia Commons At its third attempt, Replimune has finally won FDA approval for its advanced melanoma treatment RP1, giving the company its first commercial product. Now christened Tudriqev (vusolimogene oderparepvec), the oncolytic virus-based therapy has been cleared…...

1+ mon, 2+ week ago   (445+ words) A blood test for tuberculosis that could make it easier to detect people with the infection and help save lives has shown promise in a new study. Researchers led by Dr Sheng-Wei Pan of Taipei Veterans General Hospital in Taiwan…...

1+ mon, 2+ week ago   (468+ words) A dual GLP-1 and glucagon agonist developed by Altimmune has been shown to reduce drinking in people with alcohol use disorder (AUD), adding to the evidence that incretin therapies may have a role to play in addiction. In the phase…...

1+ mon, 2+ week ago   (451+ words) Two of Johnson & Johnson's multiple myeloma therapies – Tecvayli and Talvey – have dramatically improved overall survival when used as a combination therapy. In the phase 3 MonumenTAL-6 trial, Tecvayli (teclistamab) and Talvey (talquetamab) cut the risk of disease progression or death by…...